News: Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,198.00GBp
11:10am EST
Change (% chg)

7.00p (+0.59%)
Prev Close
1,191.00p
Open
1,191.00p
Day's High
1,208.00p
Day's Low
1,187.00p
Volume
2,149,191
Avg. Vol
2,690,257
52-wk High
1,211.00p
52-wk Low
858.50p

Search Stocks
Select another date:

Tue, Jan 27 2015

Stryker CEO says he remains focused on acquisitions

- The chief executive officer of U.S. medical device maker Stryker Corp , recently rumored to have been preparing a bid for British rival Smith & Nephew Plc , said on Tuesday that acquisitions are his top priority for spending cash, but he gave no hint that any sort of deal was imminent.

Stryker CEO says he remains focused on acquisitions

Jan 27 - The chief executive officer of U.S. medical device maker Stryker Corp, recently rumored to have been preparing a bid for British rival Smith & Nephew Plc , said on Tuesday that acquisitions are his top priority for spending cash, but he gave no hint that any sort of deal was imminent.

Medical device maker Smith & Nephew CEO: Big not always beautiful

- The chief executive of Smith & Nephew, the medical device maker that has been the subject of persistent takeover rumors, on Monday said mergers designed to gain size do not change market share dynamics in the hip and knee replacement business.

UPDATE 1-Two blue-chip companies drop UBS as corporate broking adviser-FT

Jan 12 - UBS Group AG, Switzerland's biggest bank, lost two more blue-chip corporate broking clients, the Financial Times reported, citing people familiar with the situation.

European Factors to Watch-Shares seen steady, health sector in focus

LONDON, Jan 12 - European shares were seen opening steady on Monday, with healthcare stocks likely to come into focus after Shire Plc agreed to buy NPS Pharmaceuticals Inc for $5.2 billion. Futures on the euro zone's blue-chip Euro STOXX 50 index rose 0.5 percent, Germany's DAX futures advanced 0.4 percent while France's CAC futures rose 0.3 percent. On Sunday, Shire agreed to buy NPS Pharmaceuticals Inc for $5.2 billion in its biggest acquisition yet, as the Dublin-b

European Factors to Watch-Shares seen steady, health sector in focus

LONDON, Jan 12 - European shares were seen opening steady on Monday, with healthcare stocks likely to come into focus after Shire Plc agreed to buy NPS Pharmaceuticals Inc for $5.2 billion. Financial spreadbetters expected Britain's FTSE 100 to open down by 10-14 points, or 0.2 percent lower. Germany's DAX was expected to open up by 11.5-31.5 points, or 0.1-0.3 percent higher, while France's CAC 40 was seen opening flat. Europe bourses in 2014: (http://link.reuters

Two blue-chip companies drop UBS as their corporate broking adviser: FT

- UBS Group AG, Switzerland's biggest bank, has lost two more blue-chip corporate broking clients, the Financial Times reported, citing people familiar with the situation.

Two blue-chip companies drop UBS as their corporate broking adviser -FT

Jan 11 - UBS Group AG, Switzerland's biggest bank, has lost two more blue-chip corporate broking clients, the Financial Times reported, citing people familiar with the situation.

Smith & Nephew outperforms sluggish European markets

LONDON - Bid speculation drove up the shares of medical devices maker Smith & Nephew on Wednesday, allowing it to outpace sluggish European stock markets in a shortened session ahead of the Christmas break. | Video

Deals of the day- Mergers and acquisitions

Dec 24 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday:

Select another date:
Search Stocks